Mirum Pharmaceuticals (NASDAQ:MIRM) reported quarterly losses of $(0.99) per share which beat the analyst consensus estimate of $(1.02) by 2.94 percent. This is a 40 percent increase over losses of $(1.65) per share from the same period last year. The company reported quarterly sales of $27.91 million which beat the analyst consensus estimate of $24.57 million by 13.58 percent. This is a 789.29 percent increase over sales of $3.14 million the same period last year.
Elon Musk’s Sister Believed He Would Go Through With Twitter Deal: ‘If He Says He’s Going To Do It…’
Tesla Inc (NASDAQ: TSLA) CEO Elon Musk’s sister Tosca Musk believed that the entrepreneur would go ahead with the purchase of Twitter Inc (NYSE: TWTR).
